Wellington Management Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Wellington Management Group's RCUS Position: Q3 2026 in Review
Wellington Management Group increased its Arcus Biosciences (RCUS) stake by 4.6% in Q3 2026, buying an estimated $7.72M and bringing the position to 6,169,222 shares worth $159M. The position accounts for 0.03% of the portfolio, ranked #414.
Wellington Management Group first reported a position in RCUS in Q1 2018 and has held it in 14 quarters since. The position peaked at $182M in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Wellington Management Group held 6,169,222 shares of Arcus Biosciences worth $159M as of Q3 2026.
- Wellington Management Group bought 273,774 Arcus Biosciences shares in Q3 2026, an estimated $7.72M.
- Arcus Biosciences made up 0.03% of Wellington Management Group's portfolio in Q3 2026, its #414 holding.
- Wellington Management Group first reported a position in Arcus Biosciences in Q1 2018 and has held it in 14 quarters since.
- Wellington Management Group's Arcus Biosciences position peaked at $182M in Q2 2026.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.